intellectual property
patent portfolioTitle
Use of Bucillamine in the Treatment of Infectious Diseases, including COVID-19
Title
62/991,996
Title
Provisional patent filed
Title
Title
Use of Bucillamine in the Treatment of Gout
Title
US9662305
Title
Granted – May 30, 2017
Title
Title
Use of Bucillamine in the Treatment of Neurological Brain Injury and Migraines
Title
63/546405
Title
Provisional patent filed
Title
Title
Method and use of Bucillamine in the Prevention and Treatment of Stroke
Title
PCT/CA2023/050425
Title
Non-Provisional patent filed
Title
Title
Bucillamine in the treatment of a victim exposed to a chemical warfare agent
Title
63/529230
Title
Provisional patent filed
Title
Title
Drug Delivery System
Title
- US 8642088
- US 9545423
- US 10104888
Title
- Issued on February 4, 2014
- Issued on January 17, 2017
- Issued on October 23, 2018
Title
Title
LONG COVID – Blood Biomarkers, Diagnosis and Treatment of Long-COVID
Title
PCT/CA2023/050145
PCT/CA2023/051292
No. 63/433,425
Title
Provisional patent filed
Title
Title
Methods for the Extraction and Crystallization of Psilocybin
Title
62/985,360
Title
Provisional patent filed
Title
Title
Psilocybin in the Treatment of Neurological Brain Injury
Title
63/011,493
Title
Provisional patent filed
Title
Title
Use of Psilocybin in the Treatment of Cancer
Title
63/133,913
Title
Provisional patent filed
Title
Title
Psilocybin Pharmaceutical Combination Therapies
Title
63/125,106
Title
Provisional patent filed
Title
Title
Use of Cannabidiol in the Treatment of Autoimmune Hepatitis
Title
US 8242178
Title
Issued on August 14, 2012
Title
USPTO No.
Status
Use of Bucillamine in the Treatment of Infectious Diseases, including COVID-19
Non-Provisional patent filed
Use of Bucillamine in the Treatment of Gout
Granted – May 30, 2017
Use of Bucillamine in the Treatment of Neurological Brain Injury and Migraines
63/546405
Provisional patent filed
Method and use of Bucillamine in the Prevention and Treatment of Stroke
PCT/CA2023/050425
Non-Provisional patent filed
Bucillamine in the treatment of a victim exposed to a chemical warfare agent
63/529230
Provisional patent filed
Drug Delvery System
US 9545423
US 10104888
Issued On January 17, 2017
Issued On October 23, 2018
LONG COVID – Blood Biomarkers, Diagnosis and Treatment of Long-COVID
PCT/CA2023/050145
PCT/CA2023/051292
No. 63/433,425
Methods for the Extraction and Crystallization of Psilocybin
62/985,360
Psilocybin in the Treatment of Neurological Brain Injury
63/011,493
Use of Psilocybin in the Treatment of Cancer
63/133,913
Psilocybin Pharmaceutical Combination Therapies
63/125,106
Use of Cannabidiol in the Treatment of Autoimmune Hepatitis